Physician profile
Brooke L Gorham
NPI 1295907087
$210,540.61
in general payments reported to CMS, 2019-2025
24 companies · $206K in 2025
The $206K reported for 2025 was more than what 99% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $73.49 · 2021: $54.03 · 2022: $3,127 · 2023: $877 · 2024: $251 · 2025: $206K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $206K · Food and Beverage: $1,063 · Travel and Lodging: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $205,900.00 |
| Food and Beverage | $1,063.22 |
| Travel and Lodging | $185.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $206,178.29 | 2023-2025 | |
| Triad Life Sciences INC. | $2,687.73 | 2021-2022 | |
| Stryker Corporation | $641.79 | 2022-2023 | Ortholoc 3di, Easyfuse, Variax |
| Paratek Pharmaceuticals, INC. | $215.71 | 2022-2025 | Nuzyra |
| Aroa Biosurgery Incorporated | $99.00 | 2022 | |
| Lifenet Health | $96.18 | 2023 | |
| Kci USA, INC. | $90.03 | 2019-2023 | Prevena, V.A.C. Veraflo, Activ.A.C. |
| Depuy Synthes Sales INC. | $56.17 | 2020-2025 | Motoband |
| Smith+Nephew, INC. | $54.46 | 2019 | |
| Grt US Holding, INC. | $45.13 | 2022 | |
| Kerecis Limited | $44.16 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Sanara Medtech INC. | $39.30 | 2021-2025 | Celleraterx |
| Integra Lifesciences Corporation | $37.86 | 2019-2020 | |
| Averitas Pharma INC. | $37.04 | 2023-2024 | Qutenza |
| Solventum Corporation | $36.13 | 2024-2025 | Promogran Prisma, Activ.A.C., Kerramax Care |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $32.26 | 2024 | Senza |
| Abbott Laboratories | $30.00 | 2022 | |
| Melinta Therapeutics, LLC | $24.97 | 2019 | |
| Orthofix Medical, INC. | $19.48 | 2023 | Physio-Stim |
| Cumberland Pharmaceuticals, INC. | $18.13 | 2020 | |
| Bioventus LLC | $14.32 | 2023 | Exogen Ultrasound Bone Healing System |
| Innovation Technologies INC | $14.30 | 2023 | Irrisept |
| Merck Sharp & Dohme LLC | $14.27 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.90 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Gorham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.